Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.40 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | FDPS | P14324 | 9/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.38 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 1/20 | 0.38 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28211171 | 0.98 | TSHR (0.39) | TSHRGGPS1EPHX1ADH1BADH1C | |
| Formaldehyde SCHEMBL15995620 | 0.96 | TSHR (0.39) | TSHRGGPS1EPHX1ADH1BADH1C | |
| SCHEMBL28422225 | 0.93 | TSHR (0.41) | TSHRGGPS1EPHX1ADH1BADH1C | |
| SCHEMBL28171004 | 0.91 | TSHR (0.37) | TSHRGGPS1EPHX1ADH1BADH1C | |
| SCHEMBL11805769 | 0.90 | TSHR (0.38) | TSHREPHX1ADH1BADH1CADH1A | |
| SCHEMBL7732151 | 0.88 | TSHR (0.44) | TSHRGGPS1EPHX1ADH1BADH1C | |
| SCHEMBL3896366 | 0.87 | TSHR (0.42) | TSHRGGPS1EPHX1ADH1BADH1C | |
| SCHEMBL8955352 | 0.87 | GGPS1 (0.39) | GGPS1FDPSFAAHTRPV1CES2 | |
| SCHEMBL7735780 | 0.86 | TSHR (0.42) | TSHRGGPS1EPHX1ADH1BADH1C | |
| SCHEMBL28626292 | 0.86 | TSHR (0.42) | TSHRGGPS1EPHX1ADH1BADH1C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3615580-B1 | A COMPOSITION USED IN 3D PRINTING SYSTEM, ITS APPLICATION THEREOF | BASF SE (DE) | 2022-06-08 | — | — | EP | claimed |
| EP-0912521-B1 | SUBSTITUTED INDAZOLE DERIVATIVES AND THEIR USE AS INHIBITORS PHOSPHODIESTERASE (PDE) TYPE IV AND THE PRODUCTION OF TUMOR NECROSIS FACTOR (TNF) | PFIZER (US) | 2005-04-06 | — | — | EP | claimed |
| EP-0690856-B1 | ANTI-TUMOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, METHODS FOR PREPARATION THEREOF AND FOR TREATMENT | UNIV NEW YORK STATE RES FOUND (US) | 2002-12-04 | — | — | EP | claimed |
| EP-0828741-B1 | SPIROCYCLIC AND BICYCLIC DIAZINYL AND CARBAZINYL OXAZOLIDINONES | UPJOHN CO (US) | 2001-08-29 | — | — | EP | claimed |
| EP-0636025-B1 | COMPOUNDS USEFUL FOR TREATING ALLERGIC OR INFLAMMATORY DISEASES | SMITHKLINE BEECHAM CORP (US) | 2001-07-18 | — | — | EP | claimed |
| EP-0727990-B1 | COMPOUNDS, COMPOSITIONS AND TREATMENT OF ALLERGIES AND INFLAMMATION | SMITHKLINE BEECHAM CORP (US) | 2001-06-13 | — | — | EP | claimed |
| EP-0558416-B1 | New 17-(methylene)-lactone spiro condensed steroids, method and intermediates for their production, their use as medicines and pharmaceutical compositions containing them | ROUSSEL UCLAF (FR) | 1996-05-22 | — | — | EP | claimed |
| EP-0157508-B1 | THIN ADHESIVE SHEET FOR USE IN WORKING SEMICONDUCTOR WAFERS | NITTO DENKO CORPORATION (JP) | 1992-07-15 | — | — | EP | claimed |
| EP-1979339-B1 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS | AVENTIS PHARMA SA (FR) | 2012-10-31 | — | — | EP | disclosed |
| EP-2094699-B1 | NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 | SANOFI AVENTIS (FR) | 2011-07-20 | — | — | EP | disclosed |
| EP-1599464-B1 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA SA (FR) | 2010-09-22 | — | — | EP | disclosed |
| EP-0861247-B1 | NOVEL IMIDAZOLE N-BENZYLDIOXOL DERIVATIVES, METHOD FOR PREPARING SAME, RESULTING INTERMEDIATES, PHARMACEUTICAL COMPOSITIONS AND USE OF SAID DERIVATIVES AS ENDOTHELIN ANTAGONISTS | AVENTIS PHARMA SA (FR) | 2009-10-07 | — | — | EP | disclosed |
| EP-2094699-A2 | NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7 | Sanofi-Aventis (FR) | 2009-09-02 | — | — | EP | disclosed |
| EP-2035408-A1 | SULPHUR-CONTAINING CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2009-03-18 | — | — | EP | disclosed |
| EP-0046001-A1 | 3-Oxo or 3-ketal, 20-oxo-diene steroid compounds, process for their preparation and their utilization in the preparation of medicines | ROUSSEL-UCLAF (FR) | 1982-02-17 | — | — | EP | disclosed |
| EP-0044575-A1 | Intermediate compounds in the preparation of 2-substituted-19-nor steroids | ROUSSEL-UCLAF (FR) | 1982-01-27 | — | — | EP | disclosed |
| EP-0004222-B1 | 4,5-SECO-ESTRANE-3,5,17-TRIONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE COMPOUNDS | ROUSSEL-UCLAF (FR) | 1981-10-28 | — | — | EP | disclosed |
| EP-0012641-A2 | Substituted-19-nor-pregn-4-ene-3,20-dione derivatives, process for their preparation and pharmaceutical compositions containing them | ROUSSEL-UCLAF (FR) | 1980-06-25 | — | — | EP | disclosed |
| EP-0007823-A2 | 3,20-Dioxo-4,9-diene-21-hydroxy-steroid compounds, process for their preparation, their use in medicines and pharmaceutical compositions containing them | ROUSSEL-UCLAF (FR) | 1980-02-06 | — | — | EP | disclosed |
| EP-0004222-A1 | 4,5-Seco-estrane-3,5,17-trione derivatives, process for their preparation and their use for the preparation of therapeutically active compounds | ROUSSEL-UCLAF (FR) | 1979-09-19 | — | — | EP | disclosed |